Clinical Trials Directory

Trials / Completed

CompletedNCT02502825

Comparison of Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers

Comparison of 2-min Tidal Breathing Methacholine Bronchial Provocation With Wright and Devilbiss646 Nebulizers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Guangzhou Institute of Respiratory Disease · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the diagnostic validity (sensitivity and specificity) and evaluate the safety of 2-min Tidal Breathing methacholine bronchial provocation tests with the Wright and Devilbiss646 nebulizers in asthmatic in Guangzhou.

Detailed description

After screening,each asthmatic patient will visit the investigators' center 4 times. During the first week, the patient will be randomised to undergo methacholine bronchial challenge with Wright or Devilbiss 646 nebulizer on two separate days, which are at least 24 hours but not more than 7 days apart.The above procedure will be repeated for each patient in one month. But the nebulizer will be selected in a reverse order.Provocative concentration induced a 20% decrease in forced expiratory volume in one second (PC20) will be calculated for each test. Record all the adverse events during the tests.

Conditions

Interventions

TypeNameDescription
OTHERmethacholinemethacholine (0.03,0.06,0.125,0.5,1.0,2.0,4.0,8.0,16.0 mg/ml),Canada
DEVICEWright Nebulizernebulized for 2 minutes with an output of 0.13ml/min
DEVICEDevilbiss646 Nebulizernebulized for 2 minutes with an output of 0.13ml/min

Timeline

Start date
2015-07-01
Primary completion
2016-07-01
Completion
2016-12-01
First posted
2015-07-20
Last updated
2018-02-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02502825. Inclusion in this directory is not an endorsement.